MedPath

Research on Parkinson's disease pathogenesis based on analysis of caffeine absorption in patients with Parkinson's disease

Not Applicable
Conditions
s disease
Parkinson&amp
#39
Registration Number
JPRN-UMIN000022187
Lead Sponsor
Department of Neurology, Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) >= 24 in Mini Mental State Examinations 2) Without heart disease, glaucoma or peptic ulcer. 3) Positive to past history of gasterointestinal surgery. 4) Presently having inflammatory bowel diseases, collagen vascular diseases, or bronchial asthma. 5) Having oral contraceptives. 6) Difficulty in withdraw caffeine intake just during 3 days before caffeine administration. 7) inappropriate cases who principle investigator identified.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
concentration changes of caffeine and its metabolites (in serum of pre-administration and 0.5 h, 1 h, 2 h, 4 h and 6 h after administration of caffeine)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath